Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells.
Sign Up to like & getrecommendations! Published in 2018 at "Current cancer drug targets"
DOI: 10.2174/1568009617666170630143931
Abstract: BACKGROUND Oncolytic viruses (OVs), which preferentially infect cancer cells and induce host anti-tumor immune responses, have emerged as an effective melanoma therapy. Tanapoxvirus (TANV), which possesses a large genome and causes mild self-limiting disease in… read more here.
Keywords: tanv 66r; human melanoma; mil; 66r mil ... See more keywords